| Financial Year |
March 31 2023 |
| Monetary Funds |
44,090,251,160.32 |
| Held-for-trading Financial Assets |
189,368,760.37 |
| Notes Receivable |
339,307,480.18 |
| Accounts Receivable |
2,864,538,385.10 |
| Advances to Suppliers |
1,600,990,767.22 |
| Other Receivables |
213,370,132.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,179,198,131.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,754,910,424.76 |
| Other Current Assets |
5,115,705,462.08 |
| Total Current Assets |
71,398,203,757.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,501,934,564.97 |
| Investment Properties |
608,611,350.04 |
| Fixed Assetes |
33,676,048,749.16 |
| Under-construction Projects |
3,697,768,679.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
1,800,278,632.11 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,692,667,958.80 |
| R&D expenses |
-- |
| Goodwill |
4,894,235,509.24 |
| Long-Term Deferred and Prepaid Expenses |
246,920,013.12 |
| Deferred Income Tax Assets |
1,545,598,922.00 |
| Other Non-Current Assets |
15,061,295,516.09 |
| Sub-Total of Non-Current Assets |
75,856,014,113.57 |
| Total Assets |
147,254,217,870.79 |
| Short-Term Loans |
39,643,343,939.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
827,798,093.10 |
| Accounts Payable |
14,764,180,908.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,200,662,938.54 |
| Taxes Payable |
988,909,289.99 |
| Interest Payable |
-- |
| Dividend Payable |
194,551,778.93 |
| Other payables |
3,215,182,804.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,097,976,515.62 |
| Other Current Liabilities |
675,512,939.65 |
| Sub-Total of Current Liabilities |
70,258,821,876.99 |
| Long-term Loans |
13,589,625,053.73 |
| Bonds Payable |
3,435,850,000.00 |
| Long-Term Accounts Payable |
34,890,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,041,305,193.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,416,640,769.79 |
| Total Liabilities |
89,675,462,646.78 |
| Paid-In Capital(Or Share Stock) |
6,398,918,718.00 |
| Capital Surplus |
14,314,349,254.09 |
| Surplus Reserve |
3,200,065,459.00 |
| LESS:Treasury Stock |
1,468,645,924.74 |
| Undistributed Profits |
31,220,845,393.05 |
| Minority Stockholder's Interest |
4,069,442,139.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,509,313,084.13 |
| Owner's Equity（Stockholder's Equity） |
57,578,755,224.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
147,254,217,870.79 |
